Evaluating the Relationships Between Rectal Normal Tissue Complication Probability and the Portion of Seminal Vesicles Included in the Clinical Target Volume in Intensity-Modulated Radiotherapy for Prostate Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 2, 2009, Pages 334-340

  Gluck, Iris ^a   Vineberg, Karen A ^a   Ten Haken, Randall K ^a   Sandler, Howard M ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Intensity modulated radiotherapy (IMRT); normal tissue complication probability (NTCP); Prostate cancer; Seminal vesicles

Indexed keywords

PROBABILITY; RADIOTHERAPY; RANDOM PROCESSES; TARGETS; VECTORS;

CLINICAL TARGET VOLUMES; DOSE RANGES; IMRT PLANNING; IMRT PLANS; INTENSITY-MODULATED RADIOTHERAPY (IMRT); NORMAL TISSUE COMPLICATION PROBABILITY (NTCP); PLANNING TARGET VOLUMES; PROSTATE CANCER; PROTOCOL REQUIREMENTS; SEMINAL VESICLES;

PHYSICAL THERAPY;

ARTICLE; CANCER PAIN; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPARATIVE STUDY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION EXPOSURE; RADIATION RESPONSE; RECTUM; SEMINAL VESICLE;

BODY BURDEN; CLINICAL PROTOCOLS; HUMANS; MALE; PROBABILITY; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM; SEMINAL VESICLES; URINARY BLADDER;

EID: 58149345582     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.09.025     Document Type: Article

References (52)

1. Baccala A., Reuther A.M., Bianco F.J., et al. Complete resection of seminal vesicles at radical prostatectomy results in substantial long-term disease-free survival: Multi-institutional study of 6740 patients. Urology 69 (2007) 536-540
2. Diaz A., Roach M., Marquez C., et al. Indications for and the significance of seminal vesicle irradiation during 3D conformal radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 30 (1994) 323-329
3. Guzzo T.J., Vira M., Wang Y., et al. Preoperative parameters, including percent positive biopsy, in predicting seminal vesicle involvement in patients with prostate cancer. J Urol 175 (2006) 518-521 discussion, 521
4. Kestin L., Goldstein N., Vicini F., et al. Treatment of prostate cancer with radiotherapy: Should the entire seminal vesicles be included in the clinical target volume?. Int J Radiat Oncol Biol Phys 54 (2002) 686-697
5. Koh H., Kattan M.W., Scardino P.T., et al. A nomogram to predict seminal vesicle invasion by the extent and location of cancer in systematic biopsy results. J Urol 170 (2003) 1203-1208
6. Lieberfarb M.E., Schultz D., Whittington R., et al. Using PSA, biopsy Gleason score, clinical stage, and the percentage of positive biopsies to identify optimal candidates for prostate-only radiation therapy. Int J Radiat Oncol Biol Phys 53 (2002) 898-903
7. Partin A.W., Yoo J., Carter H.B., et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 150 (1993) 110-114
8. Pisansky T.M., Blute M.L., Suman V.J., et al. Correlation of pretherapy prostate cancer characteristics with seminal vesicle invasion in radical prostatectomy specimens. Int J Radiat Oncol Biol Phys 36 (1996) 585-591
9. Sala E., Akin O., Moskowitz C.S., et al. Endorectal MR imaging in the evaluation of seminal vesicle invasion: Diagnostic accuracy and multivariate feature analysis. Radiology 238 (2006) 929-937
10. Davis B.J., Cheville J.C., Wilson T.M., et al. Histopathologic characterization of seminal vesicle invasion in prostate cancer: Implications for radiotherapeutic management. [abstract]. Int J Radiat Oncol Biol Phys 51 Suppl. 1 (2001) 140-141
11. Epstein J.J.I., Carmichael M.M., and Walsh P.P.C. Adenocarcinoma of the prostate invading the seminal vesicle: Definition and relation of tumor volume, grade and margins of resection to prognosis. J Urol 149 (1993) 1040-1045
12. Korman H.J., Watson R.B., Civantos F., et al. Radical prostatectomy: Is complete resection of the seminal vesicles really necessary?. J Urol 156 (1996) 1081-1083
13. Eade T.N., Hanlon A.L., Horwitz E.M., et al. What dose of external-beam radiation is high enough for prostate cancer?. Int J Radiat Oncol Biol Phys 68 (2007) 682-689
14. Jacob R., Hanlon A.L., Horwitz E.M., et al. The relationship of increasing radiotherapy dose to reduced distant metastases and mortality in men with prostate cancer. Cancer 100 (2004) 538-543
15. Kupelian P.A., Ciezki J., Reddy C.A., et al. Effect of increasing radiation doses on local and distant failures in patients with localized prostate cancer. Int J Radiat Oncol Biol Phys 71 (2008) 16-22
16. Zelefsky M.J., Fuks Z., Hunt M., et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 166 (2001) 876-881
17. Dearnaley D.P., Sydes M.R., Graham J.D., et al. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First results from the MRC RT01 randomised controlled trial. Lancet Oncol 8 (2007) 475-487
18. Kuban D.A., Tucker S.L., Dong L., et al. Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 70 (2008) 67-74
19. Hille A., Töws N., Schmidberger H., et al. A prospective three-dimensional analysis about the impact of differences in the clinical target volume in prostate cancer irradiation on normal-tissue exposure. A potential for increasing the benefit/risk ratio. Strahlenther Onkol 181 (2005) 789-795
20. Cahlon O., Hunt M., and Zelefsky M.J. Intensity-modulated radiation therapy: Supportive data for prostate cancer. Semin Radiat Oncol 18 (2008) 48-57
21. De Meerleer G.O., Fonteyne V.H., Vakaet L., et al. Intensity-modulated radiation therapy for prostate cancer: Late morbidity and results on biochemical control. Radiother Oncol 82 (2007) 160-166
22. Jani A.B., Su A., Correa D., et al. Comparison of late gastrointestinal and genitourinary toxicity of prostate cancer patients undergoing intensity-modulated versus conventional radiotherapy using localized fields. Prostate Cancer Prostatic Dis 10 (2007) 82-86
23. Vora S.A., Wong W.W., Schild S.E., et al. Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 68 (2007) 1053-1058
24. Zelefsky M.J., Chan H., Hunt M., et al. Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer. J Urol 176 (2006) 1415-1419
25. Jee K.W., McShan D.L., and Fraass B.A. Lexicographic ordering: Intuitive multicriteria optimization for IMRT. Phys Med Biol 52 (2007) 1845-1861
26. Kessler M.L., Epelman M.A., Vineberg K.A., et al. Costlets: A generalized approach to cost functions for automated optimization of IMRT treatment plans. Optim Eng 6 (2005) 421-448
27. Mackie T.R., Scrimger J.W., and Battista J.J. A convolution method of calculating dose for 15-MV x rays. Med Phys 12 (1985) 188-196
28. Tucker S.L., Dong L., Bosch W.R., et al. Fit of a generalized Lyman normal-tissue complication probability (NTCP) model to grade ≥ 2 late rectal toxicity data from patients treated on protocol RTOG 94-06. [abstract]. Int J Radiat Oncol Biol Phys 69 Suppl. 1 (2007) 8-9
29. Kutcher G.J., and Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method. Int J Radiat Oncol Biol Phys 16 (1989) 1623-1630
30. Lyman J.T. Complication probability as assessed from dose volume histograms. Radiat Res 8 (1985) S13-S19
31. Zelefsky M.J., Yamada Y., Fuks Z., et al. Long-term results of conformal radiotherapy for prostate cancer: Impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. Int J Radiat Oncol Biol Phys 71 (2008) 1028-1033
32. Litzenberg D., Dawson L.A., Sandler H., et al. Daily prostate targeting using implanted radiopaque markers. Int J Radiat Oncol Biol Phys 52 (2002) 699-703
33. Balter J.M., Lam K.L., Sandler H.M., et al. Automated localization of the prostate at the time of treatment using implanted radiopaque markers: Technical feasibility. Int J Radiat Oncol Biol Phys 33 (1995) 1281-1286
34. van der Heide U.A., Kotte A.N.T.J., Dehnad H., et al. Analysis of fiducial marker-based position verification in the external beam radiotherapy of patients with prostate cancer. Radiother Oncol 82 (2007) 38-45
35. Kupelian P.A., Langen K.M., Zeidan O.A., et al. Daily variations in delivered doses in patients treated with radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 66 (2006) 876-882
36. Dawson L.A., Mah K., Franssen E., et al. Target position variability throughout prostate radiotherapy. Int J Radiat Oncol Biol Phys 42 (1998) 1155-1161
37. de Crevoisier R., Melancon A.D., Kuban D.A., et al. Changes in the pelvic anatomy after an IMRT treatment fraction of prostate cancer. Int J Radiat Oncol Biol Phys 68 (2007) 1529-1536
38. Frank S.J., Dong L., Kudchadker R.J., et al. Quantification of prostate and seminal vesicle interfraction variation during IMRT. Int J Radiat Oncol Biol Phys 71 (2008) 813-820
39. Roeske J.C., Forman J.D., Mesina C.F., et al. Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy. Int J Radiat Oncol Biol Phys 33 (1995) 1321-1329
40. Zelefsky M.J., Crean D., Mageras G.S., et al. Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy. Radiother Oncol 50 (1999) 225-234
41. Meijer G.J., de Klerk J., Bzdusek K., et al. What CTV-to-PTV margins should be applied for prostate irradiation? Four-dimensional quantitative assessment using model-based deformable image registration techniques. Int J Radiat Oncol Biol Phys 72 (2008) 1416-1425
42. Li H.S., Chetty I.J., Enke C.A., et al. Dosimetric consequences of intrafraction prostate motion. Int J Radiat Oncol Biol Phys 71 (2008) 801-812
43. Fiorino C., Sanguineti G., Cozzarini C., et al. Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer. Int J Radiat Oncol Biol Phys 57 (2003) 953-962
44. Lee C.M., Lee R.J., Handrahan D.L., et al. Comparison of late rectal toxicity from conventional versus three-dimensional conformal radiotherapy for prostate cancer: Analysis of clinical and dosimetric factors. Urology 65 (2005) 114-119
45. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response: Results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53 (2002) 1097-1105
46. Söhn M., Yan D., Liang J., et al. Incidence of late rectal bleeding in high-dose conformal radiotherapy of prostate cancer using equivalent uniform dose-based and dose-volume-based normal tissue complication probability models. Int J Radiat Oncol Biol Phys 67 (2007) 1066-1073
47. Wachter S., Gerstner N., Goldner G., et al. Rectal sequelae after conformal radiotherapy of prostate cancer: Dose-volume histograms as predictive factors. Radiother Oncol 59 (2001) 65-70
48. Cheung M.R., Tucker S.L., Dong L., et al. Dose-volume analyses of grade ≥ 2 late rectal toxicity among patients treated on protocol RTOG 94-06. [abstract]. Int J Radiat Oncol Biol Phys 69 Suppl. 1 (2007) 9
49. Peeters S.T.H., Hoogeman M.S., Heemsbergen W.D., et al. Rectal bleeding, fecal incontinence, and high stool frequency after conformal radiotherapy for prostate cancer: Normal tissue complication probability modeling. Int J Radiat Oncol Biol Phys 66 (2006) 11-19
50. Rancati T., Fiorino C., Gagliardi G., et al. Fitting late rectal bleeding data using different NTCP models: Results from an Italian multi-centric study (AIROPROS0101). Radiother Oncol 73 (2004) 21-32
51. Ten Haken R.K., Forman J.D., Heimburger D.K., et al. Treatment planning issues related to prostate movement in response to differential filling of the rectum and bladder. Int J Radiat Oncol Biol Phys 20 (1991) 1317-1324
52. de Crevoisier R., Tucker S.L., Dong L., et al. Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 62 (2005) 965-973